NCT06951932View on ClinicalTrials.gov

Evaluation of the Impact of Medium-chain Fatty Acids in the Evolution of Newly Diagnosed Mild Cognitive Impairment

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 3, 2024

Primary Completion Date

July 3, 2025

Study Completion Date

November 3, 2025

Conditions
Mild Cognitive Impairment (MCI)
Interventions
DIETARY_SUPPLEMENT

Mediterranean-type diet with MCT supplementation

The treatment arm will follow a Mediterranean diet supplemented by daily intake of MCT (30 mL)

OTHER

Mediterranean-type food regimen using extra virgin olive oil

The arm will follow a Mediterranean diet with an indication to take extra virgin olive oil as the main fat in the diet daily

Trial Locations (1)

15121

RECRUITING

Clinical Trial Center, Alessandria

All Listed Sponsors
collaborator

Dr. Schär AG / SPA

INDUSTRY

lead

Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria

OTHER